Page-1
VICC MD 1188 An Open-Label, Phase II Study of Vemurafenib in... VICC SAR 1169 A Randomized Phase 3, Multicenter, Open-Label... COG ADVL 1121 ADVL1121 - A Phase II Study of the Raf Kinase... VICC SAR 1169 A Randomized Phase 3, Multicenter, Open-Label... VICC MD 1188 An Open-Label, Phase II Study of Vemurafenib in... VICC BRE 0889 A Multicenter Study in Patients Undergoing... COG ARST 0921 A Randomized Phase II Trial of Bevacizumab (IND#... COG ARST 08P1 A Pilot Study to Evaluate Novel Agents... Click here to print
this page (PDF) Sarcoma Flowcharts